Reducing Ischemic Kidney Injury Through Application of a Synchronization Modulation Electric Field to Maintain Na/K-ATPase Functions
Overview
Authors
Affiliations
Renal ischemia-reperfusion injury is an important contributor to the development of delayed graft function after transplantation, which is associated with higher rejection rates and poorer long-term outcomes. One of the earliest impairments during ischemia is Na/K-ATPase (Na/K pump) dysfunction due to insufficient ATP supply, resulting in subsequent cellular damage. Therefore, strategies that preserve ATP or maintain Na/K pump function may limit the extent of renal injury during ischemia-reperfusion. Here, we applied a synchronization modulation electric field to activate Na/K pumps, thereby maintaining cellular functions under ATP-insufficient conditions. We tested the effectiveness of this technique in two models of ischemic renal injury: an in situ renal ischemia-reperfusion injury model (predominantly warm ischemia) and a kidney transplantation model (predominantly cold ischemia). Application of the synchronization modulation electric field to a renal ischemia-reperfusion injury mouse model preserved Na/K pump activity, thereby reducing kidney injury, as reflected by 40% lower plasma creatinine (1.17 ± 0.03 mg/dl) in the electric field-treated group as compared to the untreated control group (1.89 ± 0.06 mg/dl). In a mouse kidney transplantation model, renal graft function was improved by more than 50% with the application of the synchronization modulation electric field according to glomerular filtration rate measurements (85.40 ± 12.18 μl/min in the untreated group versus 142.80 ± 11.65 μl/min in the electric field-treated group). This technique for preserving Na/K pump function may have therapeutic potential not only for ischemic kidney injury but also for other diseases associated with Na/K pump dysfunction due to inadequate ATP supply.
Effects of non-contact electric fields on the kidneys and livers of tumour-bearing rats.
Alamsyah F, Firdausi N, Nugraheni S, Fadhlurrahman A, Nurhidayat L, Pratiwi R F1000Res. 2025; 12:117.
PMID: 39931163 PMC: 11809679. DOI: 10.12688/f1000research.110080.3.
Lian Y, Li P, Guo Y, Tao Y, Liu Y, Liang Z Front Immunol. 2024; 15:1495394.
PMID: 39712022 PMC: 11659223. DOI: 10.3389/fimmu.2024.1495394.
Yu H, Gou X Curr Issues Mol Biol. 2024; 46(11):11853-11867.
PMID: 39590298 PMC: 11592523. DOI: 10.3390/cimb46110704.
Nanotechnology-Based Drug Delivery Systems for Treating Acute Kidney Injury.
Qin W, Huang J, Zhang M, Xu M, He J, Liu Q ACS Biomater Sci Eng. 2024; 10(10):6078-6096.
PMID: 39226188 PMC: 11480945. DOI: 10.1021/acsbiomaterials.4c01385.
Roles of Akirin1 in early prediction and treatment of graft kidney ischemia‒reperfusion injury.
Li X, Chen G, Zhou X, Peng X, Li M, Chen D Smart Med. 2024; 3(2):e20230043.
PMID: 39188701 PMC: 11235893. DOI: 10.1002/SMMD.20230043.